Odyssey Therapeutics, Inc. (ODTX)
Odyssey Therapeutics was planning to go public, but the IPO was withdrawn on Jun 9, 2025.
Stock Price: Pending
IPO price not available yet
Odyssey Therapeutics Statistics
Total Valuation
| Market Cap | n/a |
| Enterprise Value | n/a |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 14.21 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | $19,894 |
| Profits Per Employee | -$843,742 |
| Employee Count | 151 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ODTX has paid $518,000 in taxes.
| Income Tax | 518,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ODTX had revenue of $3.00 million and -$127.41 million in losses.
| Revenue | 3.00M |
| Gross Profit | 3.00M |
| Operating Income | -130.71M |
| Pretax Income | -126.89M |
| Net Income | -127.41M |
| EBITDA | -125.82M |
| EBIT | -130.95M |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has $154.90 million in cash and $32.09 million in debt, giving a net cash position of $122.81 million.
| Cash & Cash Equivalents | 154.90M |
| Total Debt | 32.09M |
| Net Cash | 122.81M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -349.27M |
| Book Value Per Share | n/a |
| Working Capital | 134.73M |
Cash Flow
In the last 12 months, operating cash flow was -$108.83 million and capital expenditures -$3.36 million, giving a free cash flow of -$112.20 million.
| Operating Cash Flow | -108.83M |
| Capital Expenditures | -3.36M |
| Free Cash Flow | -112.20M |
| FCF Per Share | n/a |
Margins
Gross margin is 100.00%, with operating and profit margins of -4,351.10% and -4,241.18%.
| Gross Margin | 100.00% |
| Operating Margin | -4,351.10% |
| Pretax Margin | -4,223.93% |
| Profit Margin | -4,241.18% |
| EBITDA Margin | -4,188.25% |
| EBIT Margin | -4,359.09% |
| FCF Margin | -3,734.95% |
Dividends & Yields
ODTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |